Related Experiment Video
Updated: Mar 2, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.8K
[Therapy of migranes].
D Holle-Lee1, S Nägel1, C Gaul2
1Klinik für Neurologie und westdeutsches Kopfschmerzzentrum, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.
Der Nervenarzt
|May 13, 2017
Summary
Effective migraine treatment involves acute therapies like NSAIDs and triptans, alongside prophylactic options such as beta-blockers and CGRP antagonists. Early intervention and non-drug approaches help prevent chronic migraine and medication overuse headaches.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine treatment encompasses acute and prophylactic strategies.
- Preventing migraine chronification and medication overuse headache is crucial.
Purpose of the Study:
- To review current and emerging therapeutic options for migraine management.
- To highlight the importance of both pharmacological and non-pharmacological interventions.
Main Methods:
- Review of existing literature on migraine treatments.
- Discussion of established and novel therapeutic agents.
- Inclusion of non-drug approaches and neuromodulation.
Main Results:
- Established acute treatments include NSAIDs and triptans.
- Prophylactic options include beta-blockers, antidepressants, and onabotulinumtoxin A.
- Emerging therapies include CGRP antagonists and monoclonal antibodies, alongside neuromodulation.
Conclusions:
- Comprehensive migraine management requires a multi-faceted approach.
- Novel CGRP-targeting therapies and neuromodulation show promise for future treatment.
- Preventive strategies are key to improving patient outcomes and reducing headache chronification.
Related Concept Videos
01:26Cholinergic Antagonists: Therapeutic Uses
1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:20Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
01:30Electroconvulsive Therapy
1.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.6K
01:28Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
745
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
745